US Map / Texas
State TX

Clinical Trials in Texas

Texas is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Texas and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 769 actively recruiting studies with Texas sites out of 769 registered in total. The busiest research areas in Texas are Breast Cancer, Advanced Solid Tumor, Endometrial Cancer. Leading sponsors running trials in the state include M.D. Anderson Cancer Center, University of Texas Southwestern Medical Center, AstraZeneca. By stage, Texas trials break down as Phase 1 (192), Phase 2 (238), Phase 3 (155), Phase 4 (25).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
769
Recruiting Now
769
← Back to US Map
Top Conditions in Texas
Breast Cancer (23)Advanced Solid Tumor (18)Endometrial Cancer (15)Ovarian Cancer (13)Acute Myeloid Leukemia (13)Colorectal Cancer (12)Heart Failure (10)Solid Tumor (10)Prostate Cancer (9)Obesity (9)Cancer (8)Advanced Solid Tumors (7)

Frequently Asked Questions — Clinical Trials in Texas

How many clinical trials are currently recruiting in Texas?
ClinicalMetric currently tracks 769 actively recruiting clinical trials with at least one location in Texas. The total number of registered studies—including active but not currently enrolling trials—is 769. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Texas?
Texas hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Advanced Solid Tumor, Endometrial Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Texas serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Texas?
To join a clinical trial in Texas, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Texas maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Texas

NCT07281118 N/A
Recruiting
Intercostal Cryoanalgesia in Double Lung Transplant Recipients
Condition
Post-operative Pain Management
Enrollment
148 pts
Location
United States
Sponsor
University of California, Los
View Trial →
NCT07119710 N/A
Recruiting
Telehealth to Improve Quality of Life in Persons Living in Rural Texas
Condition
Mental Health Issue
Enrollment
60 pts
Location
United States
Sponsor
Texas Tech University
View Trial →
NCT02693535 Phase 2
Recruiting
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That...
Condition
Lymphoma, Non-Hodgkin
Enrollment
4,200 pts
Location
United States, Puerto Rico
Sponsor
American Society of Clinical O
View Trial →
NCT07226349 Phase 1
Recruiting
A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Ad...
Condition
Advanced Solid Tumor
Enrollment
105 pts
Location
United States, Australia, China
Sponsor
BeOne Medicines
View Trial →
NCT03160274 N/A
Recruiting
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
Condition
Pheochromocytoma
Enrollment
2,000 pts
Location
United States
Sponsor
The University of Texas Health
View Trial →
NCT07361510 Phase 3
Recruiting
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participan...
Condition
Non-Small Cell Lung Cancer (NSCLC)
Enrollment
750 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT06773910 Phase 2
Recruiting
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lu...
Condition
Limited Stage Small Cell Lung Cancer
Enrollment
250 pts
Location
United States
Sponsor
SCRI Development Innovations,
View Trial →
NCT07066657 Phase 1
Recruiting
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
Condition
Locally Advanced or Metastatic Solid Tumors
Enrollment
572 pts
Location
United States, China
Sponsor
ArriVent BioPharma, Inc.
View Trial →
NCT07493265 Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
Condition
Narcolepsy
Enrollment
64 pts
Location
United States, Belgium, Canada
Sponsor
Eisai Inc.
View Trial →
NCT05335811 Phase 1
Recruiting
First-in-Human Assessment of Safety, Biodistribution and Pharmacokinetics of 18F...
Condition
Endocrine Neoplasia
Enrollment
55 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT00017914 N/A
Recruiting
Adult and Juvenile Myositis
Condition
Dermatomyositis
Enrollment
1,200 pts
Location
United States
Sponsor
National Institute of Environm
View Trial →
NCT07201558 Phase 1
Recruiting
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE P...
Condition
Rheumatoid Arthritis
Enrollment
48 pts
Location
United States, Australia, Belgium
Sponsor
AstraZeneca
View Trial →
NCT07758140 N/A
Recruiting
Comparative Self-collection for Cervical Cancer Screening Pivotal Study
Condition
HPV
Enrollment
260 pts
Location
United States
Sponsor
Mel Mont Medical
View Trial →
NCT07181876 N/A
Recruiting
Robotic Minimally Invasive Inguinal Hernia Repair Post-Market Clinical Study Wit...
Condition
Inguinal Hernia Repair
Enrollment
140 pts
Location
United States
Sponsor
Distalmotion SA
View Trial →
NCT06200155 Phase 2
Recruiting
Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenanc...
Condition
Depression, Anxiety
Enrollment
48 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT07390955 Phase 1
Recruiting
A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS i...
Condition
HIV
Enrollment
83 pts
Location
United States, Peru, Zimbabwe
Sponsor
National Institute of Allergy
View Trial →
NCT05526989 Phase 2
Recruiting
Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carc...
Condition
Penile Carcinoma
Enrollment
25 pts
Location
United States
Sponsor
H. Lee Moffitt Cancer Center a
View Trial →
NCT04752774 Phase 1, Phase 2
Recruiting
A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With...
Condition
Spasticity
Enrollment
240 pts
Location
United States, Austria, Bulgaria
Sponsor
Ipsen
View Trial →
NCT06065449 Phase 3
Recruiting
A Phase III Randomized Trial Comparing Stereotactic Body Radiation Therapy (SBRT...
Condition
Bone Metastases
Enrollment
220 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT06548789 Phase 2
Recruiting
Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Inter...
Condition
Melanoma
Enrollment
35 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT07569926 Phase 4
Recruiting
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Managemen...
Condition
Prostate Cancer
Enrollment
142 pts
Location
United States
Sponsor
Blue Earth Diagnostics
View Trial →
NCT07220876 N/A
Recruiting
Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refract...
Condition
Open Angle Glaucoma (OAG)
Enrollment
165 pts
Location
United States, South Africa
Sponsor
Avisi Technologies Inc.
View Trial →
NCT06617325 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Part...
Condition
Systemic Lupus Erythematosus
Enrollment
450 pts
Location
United States, Argentina, Belgium
Sponsor
UCB Biopharma SRL
View Trial →
NCT04079179 Phase 2
Recruiting
Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histioc...
Condition
Langerhan's Cell Histiocytosis
Enrollment
90 pts
Location
United States
Sponsor
Carl Allen
View Trial →
NCT06979362 Phase 2
Recruiting
A Research Study Comparing Different Doses of CDR132L With Placebo on the Struct...
Condition
Heart Failure
Enrollment
200 pts
Location
United States, Canada, Germany
Sponsor
Novo Nordisk A/S
View Trial →
Page 1 of 31 — 769 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology